BIOVIA is a software company headquartered in the United States, with representation in Europe and Asia. It provides software for chemical, materials and bioscience research for the pharmaceutical, biotechnology, consumer packaged goods, aerospace, energy and chemical industries.
Previously named Accelrys, it is a wholly owned subsidiary of Dassault Systèmes after an April 2014 acquisition and has been renamed BIOVIA.
Accelrys was formed in 2001 as a wholly owned subsidiary of Pharmacopeia, Inc. from the fusion of five companies: Molecular Simulations Inc., Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group (GCG), and Synomics Ltd. MSI, itself a result of the combination of Biodesign, Cambridge Molecular Design, Polygen and, later, Biocad and Biosym Technologies.
In late 2003, Pharmacopeia, Inc. separated its drug discovery and software development businesses. The drug discovery company retained the name Pharmacopeia and remained in Princeton, New Jersey, with ~170 employees. The software company, with ~530 employees and 2002 revenue of 95.1million,wouldmovetoSanDiego,California.In2004,AccelrysacquiredSciTegic,producerofthePipelinepilotsoftware.OnDecember22,2005,Accelrys,Inc.announcedtorestateitshistoricalfinancialstatements,toreflectchangestothetimingofrevenuerecognitiononcertainhistoricalterm−basedcontracts,substantiallyallofwhichwereenteredintopriortoJanuary2004.Accelrysmanagedananotechnologyconsortiumproducingsoftwaretoolsforrationalnanodesignfrom2004to2010.In2010,SymyxTechnologieswasmergedwithAccelrys.InMay2011,thecompanyacquiredConturSoftwareAB,anelectroniclabnotebooksoftwarefirm.InJanuary2012,AccelrysacquiredVelQuest,amakerofpharmaceuticalandmedicaldevice−relatedsoftware,for35 million in cash.
In May 2012, Accelrys purchased Hit Explorer Operating System (HEOS) - a SaaS system that provides groups with project information in the cloud and access to biological assay results, analytics, chemical registration and pharmacokinetics data - from Scynexis.
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.